Blonanserin

Synonym(s): Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH Formula: C145H210N42O45 Formula weight: 3261.46 CAS Number: 106686-61-7 Harmonized Tariff Code:  2937.19

Aß (12–28) residues are the binding site for apolipoprotein E (apoE) on Aß. This sequence encompasses a hydrophobic domain (residues 14–21) and a ß-turn (residues 22–28) which place two hydrophobic domains of Aß 14 to 21 and 29 to 40/42 opposite

BDE No 37

Consanguineous: No Homozygous: No Cell Line Description This cell line is an Epstein-Barr Virus (EBV) transformed lymphoblastoid line and is part of the Human Leukocyte Antigen (HLA) Typed Collection maintained by the European Collection of Cell

Biochem/physiol Actions Blonanserin is a D2/5-HT2 receptor antagonist atypical antipsychotic. Features and Benefits This compound was developed by Dainippon Sumitomo .

Biochem/physiol Actions Blonanserin is a D2/5-HT2 receptor antagonist atypical antipsychotic. Features and Benefits This compound was developed by Dainippon Sumitomo .

Cell Line Origin Human Caucasian neuroblastoma Cell Line Description Established from an abdominal mass occurring in a 13 month old Caucasian male. The tumour was diagnosed as a neuroblastoma with two rare areas of orgonoid differentiation.

Cell Line Origin Human Caucasian neuroblastoma Cell Line Description Established from a bone marrow metastasis from a 4-year-old caucasian female suffering with neuroblastoma. The cells have been used as a target cell in cell-mediated cytoxicity